Stay updated on PD1-LAG3 Bispecific Dose Escalation Clinical Trial
Sign up to get notified when there's something new on the PD1-LAG3 Bispecific Dose Escalation Clinical Trial page.

Latest updates to the PD1-LAG3 Bispecific Dose Escalation Clinical Trial page
- ChecktodayNo Change Detected
- Check8 days agoChange DetectedThe site's revision label in the footer was updated from Revision: v3.6.4 to Revision: v3.6.5, indicating a deployed update to the ClinicalTrials.gov interface.SummaryDifference0.0%

- Check15 days agoNo Change Detected
- Check22 days agoChange DetectedThe footer now displays Revision: v3.6.4, replacing the previous Revision: v3.6.3. This indicates a new site release update.SummaryDifference0.0%

- Check44 days agoChange DetectedThe page's revision label was updated from v3.6.2 to v3.6.3, indicating a new site version was applied to render this page.SummaryDifference0.0%

- Check51 days agoChange DetectedThe footer revision label changed from v3.6.0 to v3.6.2, indicating a site software update rather than changes to the study history content.SummaryDifference0.0%

- Check58 days agoChange DetectedA new study version (73) was posted on 2026-06-15, updating the Study Status in the record history. A follow-up entry on 2026-06-16 reinforces the current status, and a deletion on 2026-03-18 removes prior data from the history.SummaryDifference0.2%

- Check65 days agoChange DetectedThe study history now shows that recruitment has ended, reflecting no longer looking for participants; the record history also updates to version v3.6.0 (replacing v3.5.5).SummaryDifference0.2%

Stay in the know with updates to PD1-LAG3 Bispecific Dose Escalation Clinical Trial
Enter your email address, and we'll notify you when there's something new on the PD1-LAG3 Bispecific Dose Escalation Clinical Trial page.